Align Technology Announced $250M Accelerated Stock Repurchase Agreement

Align Technology, Inc.

Align Technology, Inc. (“Align”) (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Citibank, N.A. (“Citi”), to repurchase $250 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.

Total
0
Shares
Related Posts
Read More

Daré Bioscience Announces Grant Funding Installment To Support Further Development Of Novel Contraceptive Technology DARE-LARC1; Daré May Receive A Total Of Up To Approximately $49 Million To Support Nonclinical Development Of DARE-LARC1

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it will receive a payment of approximately $4.5 million as the latest installment under a grant agreement to advance the

DARE